E-LIB Suche - Ergebnisse für: Mark Routbort

1

ClinSeK: a targeted variant characterization framework for ..:

Zhou, Wanding ; Zhao, Hao ; Chong, Zechen...
Genome Medicine. 7 (2015) 1 - p. , 2015

Link: https://doi.org/10.1186/..

2

Mutational characteristics and clinical outcomes for lung a..:

Pan, Kelsey ; Owens, Jennifer ; Elamin, Yasir...
Journal of Thoracic Oncology. , 2024

Link: https://doi.org/10.1016/..

3

P583: PROGNOSTIC IMPLICATIONS OF WT1 MUTATIONS IN PATIENTS ..:

Atluri, Himachandana ; Patel, Keyur ; Routbort, Mark...
HemaSphere. 7 (2023) S3 - p. e15137e3 , 2023

Link: https://doi.org/10.1097/..

4

Detection of clinically actionable gene fusions by next‐gen..:

Diks, John ; Tang, Zhenya ; Altan, Mehmet...
Cancer Cytopathology. 132 (2023) 1 - p. 41-49 , 2023

Link: https://doi.org/10.1002/..

5

STAT5B mutations in myeloid neoplasms differ by disease sub..:

Yin, C. Cameron ; Tam, Wayne ; Walker, Serena M....
Haematologica. , 2023

Link: https://doi.org/10.3324/..

6

P084: Microsatellite instability and high tumor mutational ..:

Toruner, Gokce ; Yang, Richard ; Alvarez, Hector...
Genetics in Medicine Open. 1 (2023) 1 - p. 100103 , 2023

Link: https://doi.org/10.1016/..

7

Intragenic EGFR::EGFR.E1E8 Fusion (EGFRvIII) in 4331 Solid ..:

Zheng, Lan ; Luthra, Rajyalakshmi ; Alvarez, Hector A....
Cancers. 16 (2023) 1 - p. 6 , 2023

Link: https://doi.org/10.3390/..

8

PTEN in triple-negative breast carcinoma: protein expressio..:

Chen, Hui ; Ding, Qingqing ; Khazai, Laila...
Therapeutic Advances in Medical Oncology. 15 (2023) - p. , 2023

Link: https://doi.org/10.1177/..

9

P729: LANDSCAPE OF GERMLINE PATHOGENIC/ LIKELY PATHOGENIC M..:

Hein, Kimberly ; Roy Chowdhuri, Sinchita ; Dinardo, Courtney...
HemaSphere. 7 (2023) S3 - p. e9942105 , 2023

Link: https://doi.org/10.1097/..

10

DDX41 mutations in patients with non‐myeloid hematologic ne..:

Jelloul, Fatima Zahra ; Routbort, Mark. J. ; DiNardo, Courtney D....
American Journal of Hematology. 98 (2023) 8 - p. , 2023

Link: https://doi.org/10.1002/..

11

The NCI-MATCH trial: lessons for precision oncology:

O'Dwyer, Peter J. ; Gray, Robert J. ; Flaherty, Keith T....
Nature Medicine. 29 (2023) 6 - p. 1349-1357 , 2023

Link: https://doi.org/10.1038/..

12

Distinct Gene Mutations Are Associated With Clinicopatholog..:

Zaleski, Michael P ; Chen, Hui ; Roy-Chowdhuri, Sinchita...
American Journal of Clinical Pathology. 158 (2022) 2 - p. 263-269 , 2022

Link: https://doi.org/10.1093/..

13

Myelodysplastic/myeloproliferative neoplasms-unclassifiable..:

Kanagal-Shamanna, Rashmi ; Orazi, Attilio ; Hasserjian, Robert P....
Modern Pathology. 35 (2022) 4 - p. 470-479 , 2022

Link: https://doi.org/10.1038/..

14

Immunohistochemical loss of enhancer of Zeste Homolog 2 (EZ..:

Sakhdari, Ali ; Class, Caleb ; Montalban-Bravo, Guillermo...
Modern Pathology. 35 (2022) 9 - p. 1212-1219 , 2022

Link: https://doi.org/10.1038/..

15

Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy..:

Elamin, Yasir Y. ; Robichaux, Jacqulyne P. ; Carter, Brett W....
Cancer Cell. 40 (2022) 7 - p. 754-767.e6 , 2022

Link: https://doi.org/10.1016/..